Viral myocarditis

Area of Science:

• Cardiology
• Immunology
• Virology

Background:

• Myocarditis, inflammation of the heart muscle, is a significant cause of mortality, particularly in younger populations.
• It can arise from various infectious agents, leading to different inflammatory responses like lymphocytic, eosinophilic, or giant cell myocarditis.
• Myocarditis can progress to infectious dilated cardiomyopathy, often necessitating cardiac transplantation.

Purpose of the Study:

• To elucidate the pathways linking viral infection, specifically coxsackievirus B3, to the development of autoimmune myocarditis.
• To review the various manifestations and underlying mechanisms of myocarditis.
• To discuss current and future therapeutic strategies for myocarditis.

Main Methods:

• Review of existing literature on viral myocarditis and autoimmune responses.
• Analysis of experimental models using coxsackievirus B3 infection and cardiac myosin immunization in rodents.
• Discussion of diagnostic tools including endomyocardial biopsy.

Main Results:

• Viral infections can initiate distinct myocardial inflammatory patterns, potentially leading to chronic conditions.
• Persistent viral presence or autoimmune attack can drive ongoing myocarditis.
• Experimental models provide insights into the pathogenesis of coxsackievirus B3-induced myocarditis.

Conclusions:

• Distinguishing between infectious and immune-mediated myocarditis is crucial for effective treatment.
• Both pathogenic mechanisms can coexist in patients, complicating management.
• Future therapies will likely rely on advanced diagnostics like endomyocardial biopsy, immunohistology, advanced imaging, and genetic analysis for precise etiological determination.